High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia

scientific article published on September 2005

High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/SJ.BJC.6602771
P932PMC publication ID2361618
P698PubMed publication ID16222307
P5875ResearchGate publication ID7544553

P50authorPaul LoriganQ32649737
P2093author name stringLong J
Newlands ES
Hancock BW
Kanfer EJ
Seckl MJ
Haynes R
Evans LS
El-Helw LM
P2860cites workHigh-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variablesQ40925960
Choriocarcinoma and epithelial trophoblastic tumor: successful treatment of relapse with hysterectomy and high-dose chemotherapy with peripheral stem cell support: a case reportQ43941317
Successful treatment of refractory gestational trophoblastic neoplasm with high-dose etoposide and cyclophosphamideQ48610605
Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescueQ48717741
An adolescent case of retroperitoneal pure choriocarcinoma: successful treatment with MCNU-containing high-dose chemotherapy followed by autologous bone marrow transplantation after multiple brain metastasesQ49092892
Combination of high-dose chemotherapy, autologous bone marrow/peripheral blood stem cell transplantation, and thoracoscopic surgery in refractory nongestational choriocarcinoma of a 45XO/46XY female: a case report.Q53982126
High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults.Q54180890
High-Dose Chemotherapy with Autologous Bone Marrow Transplantation for Refractory Metastatic Gestational Trophoblastic DiseaseQ72053831
Failure of high-dose chemotherapy with peripheral blood stem cell support for refractory placental site trophoblastic tumorQ74625416
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectchemotherapyQ974135
P304page(s)620-621
P577publication date2005-09-01
P1433published inBritish Journal of CancerQ326309
P1476titleHigh-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia
P478volume93

Reverse relations

cites work (P2860)
Q92073766A Review on the Pathogenesis and Clinical Management of Placental Site Trophoblastic Tumors
Q92278700Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?
Q24186495Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia
Q24202503Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia
Q24235967Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia
Q57579482Chimiothérapie des tumeurs trophoblastiques gestationnelles à haut risque
Q34128850Gestational trophoblastic disease
Q43993441Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Q38260487Gestational trophoblastic tumours: an update for 2014.
Q39024033High-dose chemotherapy with autologous peripheral blood stem cell transplantation for choriocarcinoma: A case report and literature review
Q42540880Management of Chemoresistant and Quiescent Gestational Trophoblastic Disease
Q85809974Placental site trophoblastic tumor: analysis of presentation, treatment, and outcome
Q38992953Placental site trophoblastic tumors and epithelioid trophoblastic tumors: Biology, natural history, and treatment modalities
Q43740244Refractory Choriocarcinoma: Complete Response With Oral Etoposide
Q38019277Treatment of high-risk gestational trophoblastic neoplasia with weekly high-dose methotrexate-etoposide.
Q36902449Treatment of metastatic gestational trophoblastic neoplasia

Search more.